170534 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Protease inhibitors; Endopeptidase (E.C. 3.4.21-99) inhibitors Serine protease (E.C. 3.4.21) inhibitors
Sub-classes:INTER-ALPHA INHIBITOR PROTEINS AND METHODS OF USE THEREOF
#2BIOMARKER FOR DIAGNOSIS OF GASTRIC CANCER
#3THERAPEUTIC VARIANT ALPHA-2-MACROGLOBULIN COMPOSITIONS
#4FLUID TRANSFER DEVICES WITH INTEGRATED FLOW-BASED ASSAY AND METHODS OF USING THE SAME FOR IDENTIFYING SEPSIS
#5HYPOXIA BIOMARKER AND USE THEREOF
#6METHOD FOR DETERMINING PROSTATE CANCER
#7Therapeutic variant alpha-2-macroglobulin compositions
#8Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers
#9Universal Calibration Method for Assaying Enzymatic Inhibitors
#10ANTI-SERINE PROTEASE INHIBITOR KAZAL (SPIK) ANTIBODIES, IMMUNOCONJUGATES, AND METHODS OF USE
#11METHODS OF DIAGNOSING TUBERCULOSIS AND DIFFERENTIATING BETWEEN ACTIVE AND LATENT TUBERCULOSIS
#12INTER-ALPHA INHIBITOR PROTEINS AND METHODS OF USE THEREOF
#13Therapeutic variant alpha-2-macroglobulin compositions
#14Methods for quantitation of functional C1 esterase inhibitor (FC1-INH)
#15Detection of citrullinated inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4)
#16Therapeutic variant alpha-2-macroglobulin compositions
#17THERAPEUTIC VARIANT ALPHA-2-MACROGLOBULIN COMPOSITIONS
#18Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers
#19BIOMARKERS FOR GASTRIC CANCER AND USES THEREOF
#20Universal Calibration Method for Assaying Enzymatic Inhibitors
#21MULTIPLEX ASSAYS FOR EVALUATING PROSTATE CANCER STATUS
#22BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS IN FEMALE SUBJECTS
#23ALZHEIMER'S DISEASE DIAGNOSTIC PANELS AND METHODS FOR THEIR USE
#24Therapeutic variant alpha-2-macroglobulin compositions
#25Protein biomarkers for immune assessment and prediction of transplant rejection
#26Biomarkers for gastric cancer and uses thereof
#27METHOD FOR PREDICTING THE SURVIVAL STATUS AND PROGNOSIS OF ESOPHAGEAL CANCER AND A KIT THEREOF
#28Analysis of direct factor Xa inhibitors
#29Analysis of direct factor Xa inhibitors
#30ASSAYS FOR DETECTION OF GLYCOSAMINOGLYCANS
#31Biomarkers for non-alcoholic fatty liver disease, and methods for detecting non-alcoholic fatty liver disease by using such biomarkers
#32Quantifying local inflammatory activity and its use to predict disease progression and tailor treatments
#33ALZHEIMER'S DISEASE DIAGNOSTIC PANELS AND METHODS FOR THEIR USE
#34MARKER FOR PRETERM LABOUR
#35HE4 based therapy for malignant disease
#36Novel biomarker for non-alcoholic fatty liver disease, and method for detecting non-alcoholic fatty liver disease by using the biomarker
#37Competitive Differential Screening
#38ALZHEIMER'S DISEASE DIAGNOSTIC PANELS AND METHODS FOR THEIR USE
#39Quantifying local inflammatory activity and its use to predict disease progression and tailor treatments
#40Methods for detection of gastric cancer
#41Competitve differntial screeing
#42Identification and quantification of biomarkers for evaluating the risk of preterm birth
#43METHOD FOR THE DETECTION OF THE IN-VIVO ACTIVITY OF NEUROTRYPSIN, USE OF THE METHOD AND USE OF THE C-TERMINAL, 22-KDA FRAGMENT OF AGRIN AS BIOMARKER IN DIAGNOSIS AND MONITORING OF NEUROTRYPSIN-RELATED DISTURBANCES
#44Method of assaying leukocyte elastase inhibitor for the in vitro diagnosis of colorectal cancer
#45Method of determining chymase activity with secretory leukocyte protease inhibitor
#46Anti-Antiogenic Fragments of Pigment Epithelium-Derived Factor (PEDF)
#47Monoclonal antibodies for detection of urinary trypsin inhibitors
#48Pigment epithelium-derived factor as a therapeutic agent for vascular leakage
#49Method for determining the total clotting activity of a blood or plasma sample
#50Method of determining chymase activity with secretory leukocyte protease inhibitor
#51VIRAL PROTEASE
#52Monoclonal antibodies for detection of urinary trypsin inhibitors
#53Anti-angiogenic fragments fo pigment epithelium-derived factor (pedf)
#54Methods and reagents for protease inhibition
#55Methods and reagents for protease inhibition